CULVER CITY, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PROSTATE CANCER RESEARCH INSTITUTE, founded in 1997, is a community nonprofit in the Medical Research sector that reported $1.6M in total revenue in fiscal year 2024. Revenue grew 17% year-over-year, indicating healthy expansion. The organization ran a surplus of $375K, a strong 23% operating margin.
The Prostate Cancer Research Institutes (PCRI) mission is to improve the quality of mens lives by supporting research and disseminating information that educates and empowers patients, families, and the medical community. PCRI accomplishes this by:1) Empowering patients with knowledge of the most effective known treatment options that limit the risks of complications and side effects.2) Encouraging physicians to stay medically current and helping them access and actively engage with top experts in the field.3) Providing information based upon peer-reviewed medical research, literature, and reputable studies that enable patients to knowledgeably participate with their health care team in developing the best individual treatment strategy.4) Supporting research that can most immediately improve patient health outcomes.5) Advocating treatment options based on the biologic manifestations of the cancer, the patients overall health, and the outcomes desired by the patient.6) Educating through
EDUCATIONAL VIDEOS AND WEBINARS: The Support Group Video Subscription Series provides an outreach program that supplies group leaders with educational presentations and materials on a bi-monthly...
EDUCATIONAL VIDEOS AND WEBINARS: The Support Group Video Subscription Series provides an outreach program that supplies group leaders with educational presentations and materials on a bi-monthly basis.EDUCATION AND IMAGING / WEBSITE: PCRI provides the latest tools and updates that may immediately benefit patients and physicians willing to explore advances available to treat prostate cancer.
CONFERENCES: PCRI annual conferences are held virtually. Attendance is in the thousands and available for viewing free on conference dates. DVDs or streaming are available after conference dates for...
CONFERENCES: PCRI annual conferences are held virtually. Attendance is in the thousands and available for viewing free on conference dates. DVDs or streaming are available after conference dates for a minimal donation. Attended/viewed by prostate cancer patients, relatives, advocates, friends, physicians, and others in the prostate cancer community worldwide.
HELPLINE: The phone-based helpline receives about 2025 calls and emails per business day from prostate cancer patients, relatives, advocates, and the general public requesting relevant information...
HELPLINE: The phone-based helpline receives about 2025 calls and emails per business day from prostate cancer patients, relatives, advocates, and the general public requesting relevant information and guidance.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,630,544 | $1,391,142 | +0.2% |
| Expenses | $1,255,954 | $978,752 | +0.3% |
| Net Income | $374,590 | $412,390 | -0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ALEX SCHOLZ | KEY EMPLOYEE | 40.00 |
|
$147,950 | $26,300 | $174,250 |
| Mark C Scholz MD | Executive Dir. | 66.00 |
Officer
Director
|
$0 | $0 | $0 |
| Chester A Swenson | President | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| Michael L Steinberg MD | Vice President | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Steve Schwartz | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| John D Anderson | Treasurer | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| David T Robinson Jr | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Richard Citron | Secretary | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Stanley A Brosman MD | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Arthur N Lurvey MD | Director | 2.50 |
Director
|
$0 | $0 | $0 |
| Jerry E Peters | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Scott M Cohen | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,630,544 | $1,255,954 | $3,087,250 | $374,590 |
| 2024 | $1,391,142 | $978,752 | $2,552,630 | $412,390 |
| 2023 | $832,031 | $998,461 | $2,058,566 | $-166,430 |
| 2022 | $999,786 | $868,556 | $2,240,081 | $131,230 |
| 2021 | $714,337 | $752,386 | $2,195,484 | $-38,049 |
| 2020 | $642,814 | $906,403 | $2,217,805 | $-263,589 |
| 2019 | $2,014,750 | $760,342 | $2,380,525 | $1,254,408 |
| 2018 | $735,915 | $821,560 | $1,124,099 | $-85,645 |
Compare PROSTATE CANCER RESEARCH INSTITUTE with other nonprofits in California and across the country.